ESTIMATION OF G-CSF EFFECTIVENESS IN REDUCING NEUTROPENIA HOSPITALIZATION AMONG NON-HODGKIN'S LYMPHOMA (NHL) PATIENTS TREATED WITH ANTHRACYCLINE-BASED CHEMOTHERAPY

被引：0
|
作者：
Pan, X. [1 ]
Brooks, J. [1 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)72101-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A25 / A25
页数：1
相关论文
共 50 条
  • [21] Delivery of full dose CHOP chemotherapy to elderly patients with aggressive non-Hodgkin's lymphoma without G-CSF support
    Campbell, C
    Sawka, C
    Franssen, E
    Berinstein, NL
    LEUKEMIA & LYMPHOMA, 1999, 35 (1-2) : 119 - 127
  • [22] Effect of Age on Neutropenia-Related Hospitalization in Non-Hodgkin's Lymphoma Patients Receiving Myelosuppressive Chemotherapy
    Henk, Henry J.
    Deeter, Robert G.
    Kaye, James A.
    Becker, Laura K.
    Legg, Jason C.
    Rothman, Kenneth J.
    BLOOD, 2011, 118 (21) : 913 - 913
  • [23] Intensive chemotherapy (LNHIV-91 regimen) and G-CSF for HIV associated non-Hodgkin's lymphoma
    Oksenhendler, E
    Gerard, L
    Dubreuil, ML
    Levy, Y
    Matheron, S
    Cazals-Hatem, D
    Chevret, S
    Clauvel, JP
    LEUKEMIA & LYMPHOMA, 2000, 39 (1-2) : 87 - 95
  • [24] Recombinant granulocyte colony-stimulating factor (G-CSF) in patients treated with promace-cytabom for HIV-related non-Hodgkin's lymphoma (NHL)
    Rossi, G
    Re, A
    Donisi, A
    Casari, S
    Stellini, R
    Cadeo, GP
    Carosi, GP
    BLOOD, 1995, 86 (10) : 3721 - 3721
  • [25] ECONOMIC MODEL OF GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) IN PRIMARY (PP) AND SECONDARY PROPHYLAXIS (SP) OF FEBRILE NEUTROPENIA (FN) IN NON-HODGKIN'S LYMPHOMA (NHL) PATIENTS UNDERGOING CHEMOTHERAPY IN FRANCE
    Perrier, L.
    Sebban, C.
    Leon, N.
    Maurel, F.
    Cohen-Nizard, S.
    De Liege, F.
    VALUE IN HEALTH, 2011, 14 (07) : A450 - A450
  • [26] Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP
    Shikata, Hisaharu
    Yakushijin, Yoshihiro
    Yamanouchi, Jun
    Azuma, Taichi
    Yasukawa, Masaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (01) : 178 - 185
  • [27] Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP
    Hisaharu Shikata
    Yoshihiro Yakushijin
    Jun Yamanouchi
    Taichi Azuma
    Masaki Yasukawa
    International Journal of Clinical Oncology, 2014, 19 : 178 - 185
  • [28] RISK OF FEBRILE NEUTROPENIA AND USE OF G-CSF PRIMARY PROPHYLAXIS IN NON-HODGKIN'S LYMPHOMA PATIENTS RECEIVING R-CHOP-21
    Haioun, C.
    Jaeger, U.
    Lugtenburg, P.
    Pettengell, R.
    Principe, F.
    Rossi, F.
    Salar, A.
    Schwenkglenks, M.
    Verhoef, G.
    Edmundson, S.
    Bacon, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 105 - 105
  • [29] Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin’s and non-Hodgkin’s lymphoma
    E Aurlien
    H Holte
    A Pharo
    S Kvaløy
    E Jakobsen
    EB Smeland
    G Kvalheim
    Bone Marrow Transplantation, 1998, 21 : 873 - 878
  • [30] First line-intensive chemotherapy (EPOCH-G) supported with G-CSF for Non-Hodgkin Lymphoma
    Ito, Y
    Kato, C
    Horikoshi, N
    Nakane, M
    Nakano, Y
    Osawa, H
    Mihara, H
    Irie, T
    Takahashi, S
    Aiba, K
    BLOOD, 1995, 86 (10) : 201 - 201
12345